PRISMA harms checklist: improving harms reporting in systematic reviews

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

2009 • 53,927 citations

Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>

2000 • 18,725 citations

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation

2015 • 10,589 citations

The environment and disease: association or causation?

2015 • 7,281 citations

The Environment and Disease: Association or Causation?

1965 • 6,436 citations

Cochrane Handbook for Systematic Reviews of Interventions

2020 • 5,950 citations

Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials

2011 • 5,724 citations

Empirical Evidence for Selective Reporting of Outcomes in Randomized Trials

2004 • 1,728 citations

Consensus development methods, and their use in clinical guideline development.

1998 • 1,643 citations

The case of the misleading funnel plot

2006 • 1,543 citations

What to add to nothing? Use and avoidance of continuity corrections in meta‐analysis of sparse data

2004 • 1,535 citations

Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement

2004 • 1,377 citations

Reducing waste from incomplete or unusable reports of biomedical research

2014 • 1,168 citations

Guidance for Developers of Health Research Reporting Guidelines

2010 • 1,127 citations

The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews

2010 • 1,063 citations

Much ado about nothing: a comparison of the performance of meta‐analytical methods with rare events

2006 • 873 citations

Biomedical research: increasing value, reducing waste

2014 • 753 citations

Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis

2010 • 679 citations

Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis

2008 • 675 citations

Evidence-based healthcare: how to make health policy and management decisions

1999 • 634 citations

PRISMA for Abstracts: Reporting Systematic Reviews in Journal and Conference Abstracts

2013 • 603 citations

Random effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data

2010 • 590 citations

Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane reviewa

2012 • 541 citations

Completeness of Safety Reporting in Randomized Trials

2001 • 537 citations

Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research

2004 • 441 citations

PRISMA harms checklist: improving harms reporting in systematic reviews

2016 • 434 citations

Reasons or excuses for avoiding meta-analysis in forest plots

2008 • 430 citations

Increasing value and reducing waste in biomedical research: who's listening?

2015 • 415 citations

The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events

2008 • 351 citations

Reporting of Safety Results in Published Reports of Randomized Controlled Trials

2009 • 264 citations

Bias due to selective inclusion and reporting of outcomes and analyses in systematic reviews of randomised trials of healthcare interventions

2014 • 237 citations

Comparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studies

2011 • 235 citations

Why add anything to nothing? The arcsine difference as a measure of treatment effect in meta‐analysis with zero cells

2008 • 234 citations

Systematic reviews of adverse effects: framework for a structured approach

2007 • 232 citations

Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials

2011 • 226 citations

Drug safety assessment in clinical trials: methodological challenges and opportunities

2012 • 187 citations

Quality of reporting in systematic reviews of adverse events: systematic review

2014 • 185 citations

Selective reporting bias of harm outcomes within studies: findings from a cohort of systematic reviews

2014 • 182 citations

AHRQ Series Paper 4: Assessing harms when comparing medical interventions: AHRQ and the Effective Health-Care Program

2008 • 175 citations

Metamizole-Associated Adverse Events: A Systematic Review and Meta-Analysis

2015 • 150 citations

Challenges in Systematic Reviews That Assess Treatment Harms

2005 • 149 citations

The FDA extended warning for intravenous haloperidol and torsades de pointes: How should institutions respond?

2010 • 148 citations

Angiotensin receptor blockers and risk of myocardial infarction: meta-analyses and trial sequential analyses of 147 020 patients from randomised trials

2011 • 133 citations

Reporting of adverse drug reactions in randomised controlled trials – a systematic survey

2001 • 131 citations

Bisphosphonates and Atrial Fibrillation

2009 • 121 citations

Empirical vs natural weighting in random effects meta‐analysis

2009 • 119 citations

The Safety of Tiotropium — The FDA's Conclusions

2010 • 110 citations

Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials

2001 • 108 citations

Fixed vs random effects meta‐analysis in rare event studies: The Rosiglitazone link with myocardial infarction and cardiac death

2007 • 105 citations

Bi‐directional interaction between hypoglycaemia and cognitive impairment in elderly patients treated with glucose‐lowering agents: a systematic review and meta‐analysis

2015 • 101 citations

Adverse Event Reporting in Publications Compared With Sponsor Database for Cancer Clinical Trials

2006 • 101 citations

Poor reporting and inadequate searches were apparent in systematic reviews of adverse effects

2008 • 98 citations

Long-Term Developmental Outcome of Children of Women with Epilepsy, Unexposed or Exposed Prenatally to Antiepileptic Drugs

2009 • 97 citations

Safety of botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomized clinical trials

2009 • 92 citations

Assessment of therapeutic safety in systematic reviews: literature review

2001 • 91 citations

Robustness Assessments Are Needed to Reduce Bias in Meta-Analyses That Include Zero-Event Randomized Trials

2009 • 90 citations

Serenoa repens (Saw Palmetto)

2009 • 88 citations

Availability of large-scale evidence on specific harms from systematic reviews of randomized trials

2004 • 77 citations

Room for improvement? A survey of the methods used in systematic reviews of adverse effects

2006 • 74 citations

The Effect of a Bolus Dose of Etomidate on Cortisol Levels, Mortality, and Health Services Utilization: A Systematic Review

2010 • 73 citations

Assessing harmful effects in systematic Reviews

2004 • 69 citations

Maternal adverse effects of different antenatal magnesium sulphate regimens for improving maternal and infant outcomes: a systematic review

2013 • 67 citations

Reporting of adverse events in systematic reviews can be improved: survey results

2008 • 60 citations

Dexamethasone and haemorrhage risk in paediatric tonsillectomy: a systematic review and meta-analysis

2014 • 55 citations

Systematic reviews of adverse effects of drug interventions: a survey of their conduct and reporting quality

2009 • 51 citations

Clarifying the abstracts of systematic literature reviews.

2000 • 49 citations

Comprehensive evaluations of the adverse effects of drugs: importance of appropriate study selection and data sources

2011 • 48 citations

Challenges in meta-analysis of randomized clinical trials for rare harmful cardiovascular events: The case of rosiglitazone

2008 • 38 citations

A systematic review of adult admissions to ICUs related to adverse drug events

2014 • 36 citations

Some improvements are apparent in identifying adverse effects in systematic reviews from 1994 to 2011

2013 • 33 citations

Complementary medicine and safety: A systematic investigation of design and reporting of systematic reviews

2011 • 31 citations

Methodological shortcomings predicted lower harm estimates in one of two sets of studies of clinical interventions

2006 • 31 citations

Unpublished data can be of value in systematic reviews of adverse effects: methodological overview

2010 • 30 citations

Optimal type I and type II error pairs when the available sample size is fixed

2013 • 29 citations

Some concerns about adverse event reporting in randomized clinical trials.

2008 • 28 citations

THE CONTRIBUTION OF DIFFERENT INFORMATION SOURCES FOR ADVERSE EFFECTS DATA

2012 • 21 citations

Safety of Medical Interventions in Children Versus Adults

2014 • 21 citations

Reporting of meta-analyses of randomized controlled trials with a focus on drug safety: An empirical assessment

2013 • 21 citations

Failure or success of electronic search strategies to identify adverse effects data

2012 • 16 citations

Does Research Synthesis Have a Place in Drug Regulatory Policy? Synopsis of Issues: Assessment of Safety and Postmarketing Surveillance

1996 • 15 citations

Adverse Events in Healthy Individuals and MDR-TB Contacts Treated with Anti-Tuberculosis Drugs Potentially Effective for Preventing Development of MDR-TB: A Systematic Review

2013 • 13 citations

Does Research Synthesis Have a Place in Drug Regulatory Policy? Synopsis of Issues: Assessment of Efficacy and Drug Approval

1996 • 9 citations

Adverse-event rates: journals versus databases

2007 • 4 citations

Dexamethasone and Haemorrhage Risk in Paediatric Tonsillectomy

2015 • 3 citations